Stock CLBIO CORLINE BIOMEDICAL AB
Add to a list
To use this feature you must be a member
Log inSign up

Corline Biomedical AB Share Price

Equities

CLBIO

SE0006887451

Pharmaceuticals

Market Closed - Nasdaq Stockholm
Other stock markets
 04:01:07 30/04/2024 pm IST 		5-day change 1st Jan Change
10.55 SEK -.--% Intraday chart for Corline Biomedical AB -2.76% -29.19%
14/02 Corline Biomedical AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
14/02 Corline Biomedical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

Financials

Sales 2024 * 36M 3.3M 275M Sales 2025 * 179M 16.39M 1.37B Capitalization 227M 20.76M 1.73B
Net income 2024 * -6M -549K -45.84M Net income 2025 * 105M 9.61M 802M EV / Sales 2024 * 5.74 x
Net cash position 2024 * 20M 1.83M 153M Net cash position 2025 * 118M 10.8M 902M EV / Sales 2025 * 0.61 x
P/E ratio 2024 *
-36.4 x
P/E ratio 2025 *
2.16 x
Employees 13
Yield 2024 *
-
Yield 2025 *
-
Free-Float 45.17%
More Fundamentals * Assessed data

Chart Corline Biomedical AB

Dynamic Chart

Latest news about Corline Biomedical AB

Corline Biomedical AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Corline Biomedical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Corline Biomedical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Corline Biomedical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Corline Biomedical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
Corline Biomedical AB Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Corline Biomedical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Corline Biomedical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Corline Biomedical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021 CI
Corline Biomedical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Corline Biomedical AB Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Corline Biomedical AB announced that it has received SEK 35.475 million in funding from M2 Asset Management AB, HealthInvest Partners AB, and other investors CI
More news

Quotes and Performance

1 week-2.76%
Current month-11.34%
1 month-11.34%
3 months-28.47%
6 months-24.37%
Current year-29.19%
More quotes

Highs and lows

1 week
10.00
Extreme 10
11.00
1 month
10.00
Extreme 10
12.65
Current year
10.00
Extreme 10
16.80
1 year
10.00
Extreme 10
19.85
3 years
7.60
Extreme 7.6
19.85
5 years
7.60
Extreme 7.6
26.60
10 years
6.40
Extreme 6.4
31.00
More quotes

Managers and Directors - Corline Biomedical AB

Managers TitleAgeSince
Lars Henrik Nittmar CEO
 Chief Executive Officer 58 01/08/01
Gunnar Tufveson CTO
 Chief Tech/Sci/R&D Officer - 01/18/01
Magnus Nilsson BRD
 Director/Board Member 68 18/20/18
Members of the board TitleAgeSince
Magnus Nilsson BRD
 Director/Board Member 68 18/20/18
Lars Fredrik Sunnanväder BRD
 Director/Board Member - 01/05/01
Lars Adam Holger Dahlberg CHM
 Chairman 51 01/05/01
More insiders

Quotes

Date Price Change Volume
30/24/30 10.55 -.--% 1,860
29/24/29 10.55 +2.43% 16,630
26/24/26 10.3 +0.98% 3,207
25/24/25 10.2 -0.49% 6,025
24/24/24 10.25 -1.44% 13,334

Delayed Quote Nasdaq Stockholm, April 30, 2024 at 04:01 pm IST

More quotes

Company Profile

Corline Biomedical AB is a Sweden-based biotechnology company. It develops, manufactures and markets heparin-based solutions to improve kidney transplantation, cell therapies and applications in regenerative medicine.
Sector
Pharmaceuticals
Calendar
15/05/2024 - Annual General Meeting
More about the company

Income Statement Evolution

More financial data

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
CORLINE BIOMEDICAL AB Stock Corline Biomedical AB
-29.19% 20.64M
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+12.11% 9B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-12.75% 4.96B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+42.38% 4.47B
YUHAN CORPORATION Stock Yuhan Corporation
+5.23% 3.9B
INDIVIOR PLC Stock Indivior PLC
+20.51% 2.45B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-19.05% 2.41B
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-28.72% 2.23B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+11.13% 2.02B
SUPERNUS PHARMACEUTICALS, INC. Stock Supernus Pharmaceuticals, Inc.
+3.94% 1.65B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. CLBIO Stock